We are incredible excited to announce that Tamás Berke MD, MSc is joining SCARLETRED as our new Chief Medical Officer. Tamás Berke has decades of experience in anti-infective immunotherapy research and development of various stages.
He obtained his medical degree in 1991 from the University Medical School, Pécs, Hungary, then his Master of Science in medical biotechnology in 1993 from the University of Newcastle upon Tyne, England. He was a research fellow in pediatric infectious diseases, then a faculty of pediatrics at the Eastern Virginia Medical School, Norfolk, VA. Later he worked in several top-level management positions at biotech and pharma companies of various sizes, being a co-founder of one himself. Now in his new role as CMO, he will strengthen the management board in its preclinical and clinical related core business activities and further support shaping the company’s international growth and product diversification strategy.
Houskapreis 2020: SCARLETRED nominiert für Österreichs größten privaten Forschungspreis
Winner 5G Use Case Challenge
Winner of the TechBIZKON III Award in Japan
WSA IMPACT STORIES – SCARLETRED